Aims and objectives. A description and comparison of sexual activity and function in relation to various gynaecological cancer diagnoses, treatment modalities, age groups, psychological distress and health-related quality of life. Background. Various forms of gynaecological cancer have the potential to negatively influence sexual functioning, but there are few studies that describe and compare sexual activity and functioning according to diagnosis. Design. A descriptive cross-sectional study. Methods. The study includes 129 women from an intervention study. The questionnaires addressed sexuality, psychological distress, health-related quality of life and demographics. Disease and treatment characteristics were extracted from medical records.
Introduction Background
Improved treatment methods, in addition to a higher incidence of cancer and an ageing population, have resulted in an increase in the number of gynaecological cancer survivors. Consequently, there is also an increasing population of survivors suffering from side-effects of cancer treatment (Juraskova et al. 2003 , Jensen et al., 2003 Frumovitz et al. 2005 , Mercadante et al. 2010 , Lind et al. 2011 , Lammerink et al. 2012 .
The adverse effects on women's sexuality caused by the cancer treatment have been a focus of attention lately (Bergmark et al. 1999 , Liavaag et al. 2008 , Greimel et al. 2009 , Hersch et al. 2009 , Grover et al. 2012 , Vaidakis et al. 2014 . Ovarian, cervical, endometrial and vulvar cancers all have the potential to negatively influence sexual functioning, but there are few studies that describe and compare sexual activity and functioning according to diagnosis. The ongoing debate, however, is the discussion of different treatment options on sexual functioning outcomes, particularly after radiation and/or chemotherapy (Greimel et al. 2009 , Korfage et al. 2009 , Cleary & Hegarty 2011 . Regardless of diagnosis and treatment of cancer in the female genital organs, each stage of the sexual response cycle may be affected: sexual desire, arousal and orgasm (Audette & Waterman 2010 , Lammerink et al. 2012 . For instance, 33 of the 34 studies in a review (Abbott-Anderson & Kwekkeboom 2012) identified physical concerns among the gynaecological cancer survivors, for example, concerns of pain during intercourse, lubrication, vaginal dryness and vaginal atrophy.
Despite the connection between physical changes and sexuality, research on gynaecological cancer and sexuality has been criticised for its unilateral focus on physical aspects (Cleary & Hegarty 2011) and its lack of a holistic perspective. Sexuality is an integral part of human life and, as such, fundamental to a person's health. Sexuality and sexual well-being are thus complex phenomena, involving all aspects of a person's life (Hordern 2008 , Sekse et al. 2010 , Cleary et al. 2011 , Gilbert et al. 2011 , AbbottAnderson & Kwekkeboom 2012 . In addition to the physical sequelae following gynaecological cancer, the women's sexuality may also be negatively affected, due to psychological factors. Their QoL and well-being may be negatively affected by anxiety, depression, psychological distress, changes in femininity and body-image (Juraskova et al. 2003 , Reis et al. 2010 , Cleary & Hegarty 2011 , Gilbert et al. 2011 , Abbott-Anderson & Kwekkeboom 2012 , Sekse et al. 2012 .
Moreover, side-effects like fatigue and poor QoL may affect the ability and desire for sexual activity (Stead et al. 2007 , Greimel et al. 2009 , Grover et al. 2012 , McCallum et al. 2012 , Carter et al. 2013 . Not surprisingly, the effects of cancer and its treatment also had an adverse effect on intimacy and physical relationships (Ratner et al. 2010 , Abbott-Anderson & Kwekkeboom 2012 . Many women, for example, fear that intercourse may be painful (AbbottAnderson & Kwekkeboom 2012) .
Summing up, gynaecological cancer and its treatment might affect women both physically, psychologically, socially and existentially, and, by that, their quality of life and sexual life. This study's purpose was a description and comparison of sexual activity and functioning of the various gynaecological cancers according to diagnosis, treatment modality and age. Secondly, we wanted to investigate the relationship between sexual activity and functioning according to psychological distress and health-related quality of life.
Methods Participants
This study was part of a larger randomised controlled study with two test groups (educational and a physical training group), carried out between 2009 and 2012. The women were contacted mainly by mailed letters, from three different hospitals in Norway. The participants were selected based on the following criteria: female; having completed curative treatment, independent of type of gynaecological cancer and FIGO stage; age >18 years; able to walk on a treadmill; and agreement to participate, as specified by informed written consent. Exclusion criteria: significant amnesic symptoms. A total of 129 women were included in the study.
Data collection
Psychometric instruments that measure sexuality, anxiety, depression, fatigue and health-related quality of life were used to assess the women. A questionnaire specifically made for the main study was used for demographic data (age, level of education, marital status and employment status). Diagnostic and treatment information was gathered from the respondents' medical records.
The Sexual Activity Questionnaire (SAQ) is a self-report questionnaire consisting of three sections covering (1) relational status, (2) reasons for sexual inactivity and (3) sexual functioning (SAQ-F) (Thirlaway et al. 1996) .
The first section, relational status, assess whether women are sexually active or not. The sexually inactive have to complete section 2 and omit section 3. The second section contains eight possible reasons for being sexually inactive. Sexually active women complete section 3, which assesses sexual functioning that may be influenced by hormonal status: desire, frequency, satisfaction, dryness of vagina and penetration pain. The sexual functioning (SAQ-F) has a time frame of last month, and consists of 10 items. Items 1-7 of the SAQ-F are rated on a four-point scale from 'very much' to 'not at all'. We used a modified version of a Norwegian translation of the SAQ, where these seven items were instead rated 'yes' or 'no'. The SAQ discomfort items concerns 'dryness of the vagina' and 'pain and discomfort at penetration.' The SAQ pleasure items comprised the items "Was 'having sex' an important part of your life this month?", 'Did you enjoy having sex this month?', 'Did you desire to have sex with your partner last month?', 'In general, were you satisfied with your sexual activity last month?', 'How often did you engage in sexual activity last month?', and 'Were you satisfied with the frequency of sexual activity last month?'. Note that some of the questions differ somewhat in meaning from the questions in the original SAQ in Thirlaway et al. (1996) .
The Hospital Anxiety and Depression Scale (HADS) is a 14-item, 4-point ordinal response questionnaire for measuring symptoms of anxiety and depression in a nonpsychiatric context. Seven items measure anxiety, and seven items measure depression, with higher scores reflecting higher symptom loads. The questionnaire has shown good reliability and validity in primary care and in clinical populations (Bjelland et al. 2002) , and has also been used in relation to gynaecological cancer (Liavaag et al. 2009 ).
The Fatigue Questionnaire (FQ) (Chalder et al. 1993) contains 11-items measuring fatigue intensity during the preceding month. We used a modified version, translated into Norwegian. (Cella & Chalder 2010) . The translation has previously been used in a large population survey in Norwegian (Loge et al. 1998a) .
SF-36 is multidomain questionnaire measuring general health, and is not age, disease or treatment specific (Ware & Sherbourne 1992) . The response options vary from yes/ no to answers on ordinal response scales. The measure contains eight individual subscales: physical functioning (10 items), physical role limitations (4 items), bodily pain (2 items), general health (5 items), energy/vitality (4 items), social functioning (2 items), emotional role limitations (3 items) and mental health (5 items). The eight dimension scores were transformed into scales from 0 (poorest/worst health) to 100 (best health). The psychometric properties are well recognised, also in Norwegian studies (Loge et al. 1998a,b) .
Ethical considerations
The regional Committee for Medical Research Ethics (2009/895) approved the study, and all participants gave their written consent.
Data analysis
Data were stored in an SPSS data file (IBM Corp., Armonk, NY, USA), and analysed using R version 3.1.1 (R Core Team 2013). Categorical data were analysed using crosstabulation and Fisher's exact test. Continuous data were compared using Welch's two-sample t-test. Ordinal data were compared using the exact Mann-Whitney-Wilcoxon test. The results are reported as means, 95% confidence intervals, counts and percentages, along with p-values. In all analyses, p-values ≤0Á05 are considered statistically significant.
Results

Patient characteristics
Of the 129 women (mean age 57, SD 13, range 28-81), 76% were married or lived in a paired relationship. Fortyfour per cent had attended college/university. Half the women (52%) were employed and a quarter (26%) were retired (Table 1) .
Diagnosis and treatment characteristics
The mean follow-up time since diagnosis was 16 months (SD 9, range 1-38). The cancer diagnoses were uterine cancer 45%, ovarian cancer 28%, cervical cancer 24% and vulvar cancer 3% (Table 1 ). The FIGO stages were stage I (69%), stage II (11%), stage III (17%) and stage IV (3%) ( Table 1) . Most of the women (94%) were treated with surgery, and 47% were treated with surgery only, while 49% also received adjuvant chemotherapy. A total of 15% received radiation treatment.
Sexually active vs. sexually inactive
Of the 129 women, 78 were in a sexual relationship, 42 were not and 9 chose not to respond to this question. The most frequent reason for being sexual inactive were 'no partner' (50%), 'not interested in sex' (19%) and 'partner not interested in sex' (12%) (Fig. 1) . One fourth of the women (24%) had multiple reasons for being sexual inactive, while 14% did not state any reason.
Marital status and education
The differences in marital status between sexually active and inactive women are shown in Table 1 . Of the sexually active women 92% were married or lived in a paired relation, compared to 45% of the sexually inactive women. The sexually active women were on average younger (53 years compared to 61 years; p = 0Á002) than the inactive women (Table 1, Fig. 4 ). Sexually active women had higher education (although not statistically significant, p = 0Á06). There was also a positive association between having high(er) education and enjoying having sex (p = 0Á02), and with feeling satisfied with one's sexual activity (p = 0Á04), but not for the other SAQ pleasure questions.
Diagnosis, quality of life and psychological distress
There were no differences in the proportion of sexually active women with different diagnoses (all proportions between 62% and 67%, p = 0Á95), and no association between being sexually active and FIGO stage, time since diagnosis (16Á1 months vs. 16Á6 months), treatment modalities, anxiety or depression (HADS), fatigue (FQ) or frequency of physical activity per week.
There was little difference in quality of life as measured by SF-36 between sexually active and inactive women (Fig. 2) . The only statistical significant difference was on the subscale Physical functioning, where sexually active women reported better quality of life (mean scores of 87 and 81, respectively, p = 0Á02). Most of this difference was due to a greater proportion of sexually active women with the very highest scores of 95 and 100 (52% of the sexually active women vs. 24% of the not sexually active women).
SAQ-functioning (SAQ-F)
Sexual habit/frequency Of the sexually active women 89% (64/72) were engaged in sexual activity at least once in the preceding month, 1-2 times (36%), 3-4 times (25%) and 5 or more times (28%). There were no differences in frequency of sexual activity according to age, diagnosis, FIGO stage or treatment method (Table 2 ). In women reporting being sexually active, nearly 51% reported the frequency of sexual activity the preceding month to be about the same as was usual, while 35% reported a lower frequency.
Sexual pleasure and activity
Of the sexually active women 24% (17/71) were not satisfied with their sexual activity, 30% were a little satisfied, 38% somewhat satisfied and 8% very much satisfied. There were no differences related to the items measuring pleasure according to age group, diagnosis, FIGO stage or treatment.
Dryness, pain and discomfort during sexual activity
Half of the sexually active women reported vaginal dryness, 70%, 50%, 33% and 0% of the women treated for ovarian, uterine, cervical and vulvar cancer respectively (p = 0Á06).
About 41% of the sexually active women reported pain or discomfort during penetration (Fig. 3) , 50, 41, 27 and 50% of the women treated for ovarian, uterine, cervical and vulvar cancer respectively. The differences were not statistically significant (p = 0Á52).
There were no significant differences in mean age for the proportion responding 'yes' on the seven yes/no items. However, there was a higher proportion responding that they had noticed dryness in vagina for the middle age group (age 50-65), 72%, compared to 20% in the older group and 43% in the younger group (p = 0Á01). The women in the middle age group also reported more pain and discomfort during penetration, 60%, compared to 9% in the older group and 35% in the younger group (p = 0Á009). There Figure 1 Women's self-reported reasons for not being sexually active (n = 142) (It was possible to state more than one reason).
were no significant differences in reports of discomfort associated with treatment or FIGO stage.
Discussion
As far as we know, no other study offers a detailed description of sexual functioning and activity in women treated for different kinds of gynaecological cancers. Our results indicate that sexual activity decreases with age. This is in line with Vistad et al. (2007a) , who reported a decrease in sexual activity with increasing age. Furthermore, women in our study are less sexually active compared to the normative sample in Vistad's study (2007a) . Still, nearly twothirds of the women had participated in sexual activity the (2007b) showed that 30% of the cervical cancer survivors were sexually active during the last month. The women in this study reported a lower level of sexual pleasure and a higher level of discomfort compared to a normative sample (Vistad et al. 2007a) . Over half of the sexually active women were not satisfied or little satisfied with their sexual activity. Also, about half of the women reported vaginal dryness. The percentage varied among women with ovarian cancer (70%), uterine cancer (50%) and cervical cancer (33%). Overall 41% of the sexually active women reported pain or discomfort during penetration. A negative impact on sexual functioning over time in women who have had gynaecological cancer is also well documented (Bergmark et al. 1999 , Stewart et al. 2001 , Park et al. 2007 , Sekse et al. 2010 . Lack of sexual interest, physical problems and fear of pain during intercourse are some of the difficulties mentioned. For example, in a study of disease-free long-term survivors (n = 860) with a history of cervical cancer, participants reported reduced sexual functioning and performance compared to healthy controls (Park et al. 2007) . In a review (Abbott-Anderson & Kwekkeboom 2012), physical concerns, vaginal dryness and pain was a deterrent to participating in sexual activity. However, despite findings in our study and some other studies that reveal pain and discomfort (which comprise sexual activity), women's sexual activity appears to be very similar to healthy controls', even in a long-term perspective (Bergmark et al. 1999) . How are we to understand this? One perspective might be that the women have a desire to maintain their sexual lives, and to have the same level of intimacy with their partners as before cancer diagnosis and treatment. This might be explained by their wish to maintain their sexual life primarily to satisfy their partners rather than themselves (Bergmark et al. 1999) . In a qualitative study by Juraskova et al. (2003) the findings revealed that intimacy rather than physical acts of sexual intercourse was desired by the women, but was not sufficient to satisfy their partners. Some women may thus set aside their own needs to resume their normal lives. Nevertheless, it is reasonable to assume that pain during sex reduces the women's pleasure. The somewhat low frequencies of sexual activity in our study should thus be seen in the light of the women's challenges following gynaecological cancers.
Even though there is debate and conflicting opinion with regard to what treatment options are more detrimental to sexuality following gynaecological cancer, several studies have found that sexual problems are particularly related to adjuvant radiotherapy and chemotherapy (HawighorstKnapstein et al. 2004 , Korfage et al. 2009 , Lind et al. 2011 , Lammerink et al. 2012 . One might expect that women treated with radiation and/or chemotherapy would report lower levels of 'pleasure' and higher levels of 'discomfort'. Surprisingly, this study found no significant differences on pleasure and discomfort related to treatment modality, diagnosis or FIGO stage. Our results correspond with recent studies that have found no significant differences in sexual functioning related to adjuvant therapy compared to those with main treatment (Becker et al. 2011 , Nout et al. 2011 , Onujiogu et al. 2011 ). For example, Nout et al. (2011 reported that there was no significant difference in sexual morbidity between the (n = 246) endometrial cancer survivors who received external beam radiotherapy and those who received no adjuvant therapy.
Many of the sexually inactive women were older (Fig. 4) . This is also in line with other studies (Carmack Taylor et al. 2004 , Lai et al. 2009 ). In contrast, Bifulco et al. (2012) found that out of (n = 263) early stage gynaecological cancer survivors (divided into two groups, older and younger than 45 years) younger women were significantly more affected by impaired sexuality. The study showed that the younger women had less sexual activity than midlife adults, suffered more from poor body image, perceived poorer sexual vaginal functioning and had more severe menopausal symptoms. Although the age groups are not directly comparable, this seems to be in contrast with Vistad et al. (2007b) study, where a higher proportion of the women in the middle age group (age 50-65) reported dryness in vagina and more pain and discomfort during penetration. In the normative study by Vistad et al. (2007a,b) the oldest age group reported significantly less pleasure and more discomfort compared to the younger women. The oldest age group (age 56-69) in Vistad's study was younger than in our study (age 66-81), which may indicate even greater differences in discomfort when comparing the two studies. One explanation may be that the oldest women in the present study have been through a normal menopause and become accustomed to dryness and other ailments before treatment for gynaecological cancer, while the middle age group may have experienced being thrown into a more severe menopause because of the cancer treatment.
We found that a majority of survivors after various types of gynaecological cancer and treatment modalities reported a relatively satisfactory quality of life, despite bodily ailments, discomforts and changes in sexual life. This finding is also echoed in other studies on gynaecological cancer (Harter et al. 2013) , also in a long-term perspective (Stewart et al. 2001) . To understand this, researchers have interpreted it partly in light of 'response shift' (Sprangers & Schwartz 1999) . Sprangers and Schwartz (1999) states that a person's values will most likely be affected following a serious illness. The response shift involves a shift in personal standards, values and perception of quality of life. What is regarded as important in life may change after surviving a life-threatening illness. According to many studies, women seem to experience a positive shift in their perspectives on life, side-effects notwithstanding, after gynaecological cancer, and feel enriched. (Ponto et al. 2010 , Sekse et al. 2010 , Stewart et al. 2001 . The women may have experienced a change in priorities that partially compensates for other, more negative, changes. As such, the women's sense of loss concerning sexual functioning may change after cancer illness (Stewart et al. 2001 , Harter et al. 2013 .
Study limitations
The study had a relatively small sample (N = 129), with even fewer participants qualified to complete all sections of the questionnaire. There were only three women diagnosed with vulvar cancer, and the study is thus not representative of all women facing type of cancer. Since we have no data related to the sexuality of the women prior to cancer diagnosis and treatment, we cannot draw strong conclusions on the longitudinal effect of gynaecological cancer and cancer treatment on sexual activity and functioning.
Furthermore, the results may not apply to the general population of survivors of gynaecological cancer, as the sample consisted of women who had already agreed to take part in an extensive intervention study.
The focus of the questionnaire used in this study was sexual function and activity. Sexuality is certainly a more complex phenomenon than what is reflected through those aspects, and a study would benefit from a broader approach. The negative effects of gynaecological cancer and its treatment are likely to be recognised also in the psychological and social aspects of sexuality and quality of life. A broader perspective by adding a qualitative element, for example, open-ended questions, to the survey, may be one way to explore the phenomenon to a wider extent. This could also lead to improved nursing care and practice. 
Conclusion
This study shows that although women after gynaecological cancer are sexually active, more than 50% are not satisfied or little satisfied with this part of their life. They also report high scores on pain and discomfort related to sexual activity. Sexuality is a significant part of a woman's life, and health personnel should address the issue during treatment and follow-up.
Relevance to clinical practice
Health personnel should develop a greater understanding of the challenges cancer poses to a woman's sexuality, and should address these in any interaction with the patients, considering sexual function, response cycle, body image and sexual relationships. The personnel's ability to communicate and their expertise in diagnosing and treating difficulties relating to sexuality are important. Furthermore, any counselling consultation on the issue should also be accompanied by written information to ensure that the information is received by the patient.
